These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Oral antibiotic treatment for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: review of the literature. Khawcharoenporn T; Alan T Hawaii Med J; 2006 Oct; 65(10):290-3. PubMed ID: 17194061 [TBL] [Abstract][Full Text] [Related]
23. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin. Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975 [TBL] [Abstract][Full Text] [Related]
24. Topical antibiotic treatment for uncomplicated skin and skin structure infections: review of the literature. Pangilinan R; Tice A; Tillotson G Expert Rev Anti Infect Ther; 2009 Oct; 7(8):957-65. PubMed ID: 19803705 [TBL] [Abstract][Full Text] [Related]
25. Daptomycin: rationale and role in the management of skin and soft tissue infections. Seaton RA J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii15-23. PubMed ID: 18829721 [TBL] [Abstract][Full Text] [Related]
26. Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community. van Bijnen EM; Paget WJ; den Heijer CD; Stobberingh EE; Bruggeman CA; Schellevis FG; BMC Fam Pract; 2014 Oct; 15():175. PubMed ID: 25413920 [TBL] [Abstract][Full Text] [Related]
27. Oral beta-lactams applied to uncomplicated infections of skin and skin structures. Jacobs MR; Jones RN; Giordano PA Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):55S-65S. PubMed ID: 17292581 [TBL] [Abstract][Full Text] [Related]
28. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities. Cohen PR South Med J; 2005 Jun; 98(6):596-602. PubMed ID: 16004165 [TBL] [Abstract][Full Text] [Related]
29. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis. Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644 [TBL] [Abstract][Full Text] [Related]
30. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus. Phillips S; MacDougall C; Holdford DA Ann Pharmacother; 2007 Jan; 41(1):13-20. PubMed ID: 17200425 [TBL] [Abstract][Full Text] [Related]
31. Skin and soft tissue infections in intercontinental travellers and the import of multi-resistant Staphylococcus aureus to Europe. Nurjadi D; Friedrich-Jänicke B; Schäfer J; Van Genderen PJ; Goorhuis A; Perignon A; Neumayr A; Mueller A; Kantele A; Schunk M; Gascon J; Stich A; Hatz C; Caumes E; Grobusch MP; Fleck R; Mockenhaupt FP; Zanger P Clin Microbiol Infect; 2015 Jun; 21(6):567.e1-10. PubMed ID: 25753191 [TBL] [Abstract][Full Text] [Related]
32. Staphylococcal Skin and Soft Tissue Infections. Hatlen TJ; Miller LG Infect Dis Clin North Am; 2021 Mar; 35(1):81-105. PubMed ID: 33303329 [TBL] [Abstract][Full Text] [Related]
33. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Pallin DJ; Egan DJ; Pelletier AJ; Espinola JA; Hooper DC; Camargo CA Ann Emerg Med; 2008 Mar; 51(3):291-8. PubMed ID: 18222564 [TBL] [Abstract][Full Text] [Related]
34. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Lee MC; Rios AM; Aten MF; Mejias A; Cavuoti D; McCracken GH; Hardy RD Pediatr Infect Dis J; 2004 Feb; 23(2):123-7. PubMed ID: 14872177 [TBL] [Abstract][Full Text] [Related]
35. Hospitalist perspective on the treatment of skin and soft tissue infections. Amin AN; Cerceo EA; Deitelzweig SB; Pile JC; Rosenberg DJ; Sherman BM Mayo Clin Proc; 2014 Oct; 89(10):1436-51. PubMed ID: 24974260 [TBL] [Abstract][Full Text] [Related]
36. [Community-associated methicillin-resistant Staphylococcus aureus infections among children in the western Galilee region: the beginning of an epidemic?]. Glikman D Harefuah; 2009 Nov; 148(11):761-5, 794, 793. PubMed ID: 20027978 [TBL] [Abstract][Full Text] [Related]
37. Early appropriate parenteral antimicrobial treatment of complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Napolitano LM Surg Infect (Larchmt); 2008; 9 Suppl 1():s17-27. PubMed ID: 18844471 [TBL] [Abstract][Full Text] [Related]
38. Treatment of infections caused by resistant Staphylococcus aureus. Anstead GM; Quinones-Nazario G; Lewis JS Methods Mol Biol; 2007; 391():227-58. PubMed ID: 18025681 [TBL] [Abstract][Full Text] [Related]
39. Sensitivity to antibacterials of Staphylococcus aureus isolated from different types of skin infections. Nishijima S; Namura S; Nakagawa M; Kurokawa I; Kawabata S J Int Med Res; 1997; 25(1):1-7. PubMed ID: 9027667 [TBL] [Abstract][Full Text] [Related]